Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma.

Zhang ZC, Li YY, Wang HY, Fu S, Wang XP, Zeng MS, Zeng YX, Shao JY.

PLoS One. 2014 Jan 21;9(1):e86149. doi: 10.1371/journal.pone.0086149. eCollection 2014.

2.

Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma.

Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S, Long X, Jiang Q, Song Y, Cheng C, Wang H, Zhao M, Fu Q, Lyu X, Chen Y, Fan Y, Liu Y, Li X, Fang W.

Cell Death Dis. 2013 Oct 24;4:e872. doi: 10.1038/cddis.2013.376.

3.

MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.

Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL, Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, Fu L.

Carcinogenesis. 2013 Feb;34(2):454-63. doi: 10.1093/carcin/bgs346. Epub 2012 Nov 3.

4.

Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.

Ou H, Li Y, Kang M.

PLoS One. 2014 Nov 3;9(11):e109929. doi: 10.1371/journal.pone.0109929. eCollection 2014.

5.

miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.

Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, McCarthy JB, She X, Zhang W, Ma J, Xiong W, Wu M, Lu J, Li X, Li X, Xiang J, Li G.

Carcinogenesis. 2013 Feb;34(2):415-25. doi: 10.1093/carcin/bgs329. Epub 2012 Oct 24.

6.

miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.

Deng M, Ye Q, Qin Z, Zheng Y, He W, Tang H, Zhou Y, Xiong W, Zhou M, Li X, Yan Q, Ma J, Li G.

Tumour Biol. 2013 Jun;34(3):1793-800. doi: 10.1007/s13277-013-0718-y. Epub 2013 Mar 13.

PMID:
23479198
7.

MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.

Zhang H, Zuo Z, Lu X, Wang L, Wang H, Zhu Z.

Oncol Rep. 2012 Feb;27(2):594-8. doi: 10.3892/or.2011.1530. Epub 2011 Nov 8.

PMID:
22076535
8.

miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis.

Cheung CC, Chung GT, Lun SW, To KF, Choy KW, Lau KM, Siu SP, Guan XY, Ngan RK, Yip TT, Busson P, Tsao SW, Lo KW.

Mol Cancer. 2014 Aug 7;13:184. doi: 10.1186/1476-4598-13-184.

9.

MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.

Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, O'Sullivan B, Liu FF.

Cancer Res. 2011 Mar 15;71(6):2381-91. doi: 10.1158/0008-5472.CAN-10-2754. Epub 2011 Mar 8.

10.

TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness.

Lyu X, Fang W, Cai L, Zheng H, Ye Y, Zhang L, Li J, Peng H, Cho WC, Wang E, Marincola FM, Yao K, Cai H, Li J, Li X.

Mol Cancer. 2014 Mar 8;13:51. doi: 10.1186/1476-4598-13-51.

11.

MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.

Li YQ, Ren XY, He QM, Xu YF, Tang XR, Sun Y, Zeng MS, Kang TB, Liu N, Ma J.

Cell Death Dis. 2015 Jan 22;6:e1618. doi: 10.1038/cddis.2014.582.

12.

Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.

Du ZM, Hu LF, Wang HY, Yan LX, Zeng YX, Shao JY, Ernberg I.

PLoS One. 2011 Apr 26;6(4):e19137. doi: 10.1371/journal.pone.0019137.

13.

Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling.

Xu YF, Li YQ, Guo R, He QM, Ren XY, Tang XR, Jia WH, Kang TB, Zeng MS, Sun Y, Ma J, Liu N.

Int J Biochem Cell Biol. 2015 Apr;61:120-8. doi: 10.1016/j.biocel.2015.02.006. Epub 2015 Feb 18.

PMID:
25701793
14.

MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma.

Liu N, Jiang N, Guo R, Jiang W, He QM, Xu YF, Li YQ, Tang LL, Mao YP, Sun Y, Ma J.

Mol Cancer. 2013 Oct 20;12(1):123. doi: 10.1186/1476-4598-12-123.

15.

MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.

Liu N, Tang LL, Sun Y, Cui RX, Wang HY, Huang BJ, He QM, Jiang W, Ma J.

Cancer Lett. 2013 Feb 28;329(2):181-8. doi: 10.1016/j.canlet.2012.10.032. Epub 2012 Nov 8.

PMID:
23142282
16.

MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma.

Qi X, Li J, Zhou C, Lv C, Tian M.

FEBS Lett. 2014 Oct 16;588(20):3732-8. doi: 10.1016/j.febslet.2014.08.021. Epub 2014 Aug 27.

17.

Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.

Gao W, Chan JY, Wong TS.

Clin Sci (Lond). 2014 Nov;127(9):571-9. doi: 10.1042/CS20140010.

PMID:
24896104
18.

miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.

Deng M, Tang H, Zhou Y, Zhou M, Xiong W, Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, Li X, Ma J, Li G.

J Cell Sci. 2011 Sep 1;124(Pt 17):2997-3005. doi: 10.1242/jcs.085050.

19.

Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth.

Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, Fu J, Zeng MS, Yun JP, Wu QL, Zeng YX, Shao JY.

Breast Cancer Res. 2011 Jan 10;13(1):R2. doi: 10.1186/bcr2803.

20.

MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.

Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, Zhou X, Xie G, Kang T, Wang H, Zeng M, Ma J, Zeng Y, Yun JP.

Oncogene. 2012 Oct 11;31(41):4421-33. doi: 10.1038/onc.2011.629. Epub 2012 Jan 16.

PMID:
22249270
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk